APPLICATION
Application Note
*Optimal dilutions/concentrations should be determined by the researcher.
Application |
Recommended Dilution |
1:50-1:100 |
Note :
IHC-P
Standard ABC technique.
|
Not tested in other applications.
Calculated MW
PROPERTIES
Form
Liquid
Buffer
Tissue culture supernatant
Preservative
0.09% Sodium azide
Storage
Store as concentrated solution. Centrifuge briefly prior to opening vial. Store at 4ºC.
Antigen Species
Human
Immunogen
A 227 amino acid region of the external domain of the human VEGFR-3 molecule.
Purification
Unpurified
Conjugation
Unconjugated
Note
For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.
TARGET
Synonyms
fms related tyrosine kinase 4 , FLT-4 , FLT41 , LMPH1A , LMPHM1 , PCL , VEGFR-3 , VEGFR3
Cellular Localization
Cell membrane , Cytoplasm , Nucleus
Background
This gene encodes a tyrosine kinase receptor for vascular endothelial growth factors C and D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. Mutations in this gene cause hereditary lymphedema type IA. [provided by RefSeq, Jul 2008]
Database
Research Area
DATA IMAGES
|
GTX01880 IHC-P Image
IHC-P analysis of human placenta tissue using GTX01880 VEGF Receptor 3 antibody [KLT9].
|
REFERENCE
There are currently no references for VEGF Receptor 3 antibody [KLT9] (GTX01880). Be the first to share your publications with this product.
REVIEW
There are currently no reviews for VEGF Receptor 3 antibody [KLT9] (GTX01880). Be the first to share your experience with this product.